ACTINIUM PHARMACEUTICALS, INC. Payments to Acquire Finance Receivables
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Payments to Acquire Finance Receivables of $72.70 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireFinanceReceivables · last filed 2020-05-08
- ACTINIUM PHARMACEUTICALS, INC. payments to acquire finance receivables for the quarter ending 2019-12-31 was $18.72K.
- ACTINIUM PHARMACEUTICALS, INC. payments to acquire finance receivables for the quarter ending 2019-09-30 was $18.35K.
- ACTINIUM PHARMACEUTICALS, INC. payments to acquire finance receivables for the quarter ending 2019-06-30 was $17.99K.
- ACTINIUM PHARMACEUTICALS, INC. payments to acquire finance receivables for the quarter ending 2019-03-31 was $17.64K.
- ACTINIUM PHARMACEUTICALS, INC. payments to acquire finance receivables for fiscal 2019 was $72.70K.
| Period end | Payments to Acquire Finance Receivables 3 month | Payments to Acquire Finance Receivables 6 month | Payments to Acquire Finance Receivables 9 month | Payments to Acquire Finance Receivables 12 month |
|---|---|---|---|---|
| 2019-12-31 | $18.72K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | $37.07K derived: sum of 2 quarters · filed 2020-05-08 | $55.06K derived: sum of 3 quarters · filed 2020-05-08 | $72.70K 10-K · filed 2020-05-08 |
| 2019-09-30 | $18.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $36.34K derived: sum of 2 quarters · filed 2019-11-12 | $53.98K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $17.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $35.62K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $17.64K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |